Page last updated: 2024-09-03

cgs 25462 and atrial natriuretic factor

cgs 25462 has been researched along with atrial natriuretic factor in 1 studies

Compound Research Comparison

Studies (cgs 25462)	Trials (cgs 25462)	Recent Studies (post-2010) (cgs 25462)	Studies (atrial natriuretic factor)	Trials (atrial natriuretic factor)	Recent Studies (post-2010) (atrial natriuretic factor)
7	0	0	15,455	1,105	1,760

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Lombaert, S; Erion, MD; Ghai, RD; Lappe, RW; Peppard, JV; Trapani, AJ; Worcel, M	1

Other Studies

1 other study(ies) available for cgs 25462 and atrial natriuretic factor

Article	Year
The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:5 Topics: Administration, Oral; Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Biological Availability; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Molecular Sequence Data; Neprilysin; Oligopeptides; Organophosphonates; Prodrugs; Rats; Substrate Specificity	1993

Article

Year

The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:5

Topics: Administration, Oral; Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Biological Availability; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Molecular Sequence Data; Neprilysin; Oligopeptides; Organophosphonates; Prodrugs; Rats; Substrate Specificity

1993